RE:RE:RE:From bad to worseIt's the only drug approved for Lypo and it's a problem not linked to Egrifta manufacturing itself. The plant has issues that they need fixing and I one of the consequence is the FDA approval of new batch. They might loose a few months of Egrifta sales and that can be a problem.